Menu
Back to Journals » Therapeutics and Clinical Risk Management » Volume 18
Review
A Profile of Avelumab Plus Axitinib in the Treatment of Renal Cell Carcinoma
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 6,130 | Dovepress* | 5,643+ | 273 | 5,916 | |
| PubMed Central* | 487 | 128 | 615 | ||
| Totals | 6,130 | 401 | 6,531 | ||
| *Since 8 July 2022 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed and Google Scholar